The Technical AnalystExchange: XETRA Industry: Health Care Equipment & Services
Coloplast A/S Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.84% €112.60
Europe/Berlin / 2 mai 2024 @ 17:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 25 072 mill |
| EPS: | 2.99 |
| P/E: | 37.66 |
| Earnings Date: | May 07, 2024 |
| SharesOutstanding: | 222.67 mill |
| Avg Daily Volume: | 0.0004 mill |
| RATING 2024-05-02 |
|---|
| S |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Strong Buy | |
| P/E: | Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | |||||
| Gr.Profit | n/a | |||||
| Ebit | n/a | |||||
| Asset | n/a | |||||
| Debt | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 2.07x |
| Company: PE 37.66 | sector: PE 18.22 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.26x |
| Company: PE 37.66 | industry: PE 29.80 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€83.33 (-25.99%) €-29.27 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
€ 110.54 - 114.66 ( +/- 1.83%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | €112.60 (-0.84% ) |
| Volume | 0.0002 mill |
| Avg. Vol. | 0.0004 mill |
| % of Avg. Vol | 59.75 % |
| Signal 1: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CBHD.DE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CBHD.DE
Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.